Siemens merges ultrasound sales and service

Article

While Diasonics set up a separate company to sell Vingmed ultrasoundscanners in the U.S. cardiology market, Siemens moved in the oppositedirection last month. The German vendor initiated consolidationof the sales and service staff of its

While Diasonics set up a separate company to sell Vingmed ultrasoundscanners in the U.S. cardiology market, Siemens moved in the oppositedirection last month. The German vendor initiated consolidationof the sales and service staff of its cardiology-focused ultrasounddivision in San Ramon, CA, with the radiology and vascular groupat Quantum Medical Systems in Issaquah, WA.

Both ultrasound offices will be retained in the consolidationprocess, and the two brand names will continue for the time being,said Lonnie Edelheit, Quantum president.

Siemens' acquisition of Quantum a year ago (SCAN 4/11/90) provideda foothold in the high-end radiology ultrasound market. Siemensbases its worldwide ultrasound business unit in the U.S.

Like most other multimodality medical imaging companies, Siemenshas had to play catch-up with smaller, dedicated ultrasound firmsthat have been successful in the technology-intensive radiologyultrasound field.

Siemens decided to combine the two sales and service groupsto provide a unified focus for its ultrasound business and improveresponsiveness to customers, Edelheit told SCAN. The unified salesand service group will handle scanners in the cardiac, radiology,vascular and ob/gyn private-office markets.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.